国际口腔医学杂志

国际口腔医学杂志 ›› 2020, Vol. 47 ›› Issue (6): 669-676.doi: 10.7518/gjkq.2020088

• 综述 • 上一篇    下一篇

光动力疗法在口腔黏膜癌变防治中的应用

何宇晴(),但红霞(),陈谦明   

  1. 口腔疾病研究国家重点实验室 国家口腔疾病临床医学研究中心 口腔黏膜病国家临床重点专科 中国医学科学院口腔黏膜癌变与防治创新单元 四川大学华西口腔医院黏膜病科 成都 610041
  • 收稿日期:2019-11-14 修回日期:2020-06-02 出版日期:2020-11-01 发布日期:2020-11-06
  • 通讯作者: 但红霞
  • 作者简介:何宇晴,硕士,Email： 1193746389@qq.com
  • 基金资助:
    国家自然科学基金(81572663)

Application of photodynamic therapy for oral carcinogenesis prevention

He Yuqing(),Dan Hongxia(),Chen Qianming   

  1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & National Key Laboratory of Oral Mucosal Diseases & Innovation Unit of Oral Mucosal Carcinogenesis and Prevention, Chinese Academy of Medical Sciences & Dept. of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2019-11-14 Revised:2020-06-02 Online:2020-11-01 Published:2020-11-06
  • Contact: Hongxia Dan
  • Supported by:
    National Nature Science Foundation of China(81572663)

RichHTML

42

PDF (PC)

518

摘要：

口腔黏膜癌变是从正常口腔黏膜发展为口腔黏膜潜在恶性疾患,最终成为口腔癌的过程。通常的治疗目标是在癌变早期进行干预,防止癌变发生,但目前为止缺少疗效确切且安全的治疗方法。光动力疗法是一种基于光敏剂介导的光化学、光生物学反应,对病变细胞产生杀伤作用的治疗手段,在治疗疾病、改善预后等方面具有诸多优点,是口腔黏膜潜在恶性疾患及口腔鳞状细胞癌的一种新的治疗选择。本文主要对光动力疗法及其在口腔黏膜癌变防治中的应用进行综述。

关键词: 光动力疗法, 口腔黏膜潜在恶性疾患, 口腔鳞状细胞癌, 光敏剂

Abstract:

Oral carcinogenesis starts from the oral mucosa to oral potentially malignant disorder (OPMD) and eventually leads to oral cancer. Substantial effort has been directed to prevent oral carcinogenesis at its early stage; however, success is elusive. Photodynamic therapy is based on photosensitiser-mediated photochemical and photobiological effects leading to cellular damage in lesional tissues. This technique is a new treatment option for OPMD and oral squamous cell carcinoma. This article reviewed the application of photodynamic therapy for oral carcinogenesis prevention.

Key words: photodynamic therapy, oral potentially malignant disorders, oral squamous cell carcinoma, photosensitizer

中图分类号: 

  • R781.5
[1] Ganesh D, Sreenivasan P, Öhman J, et al. Potentially malignant oral disorders and cancer transformation[J]. Anticancer Res, 2018,38(6):3223-3229.
pmid: 29848669
[2] Mello FW, Miguel AFP, Dutra KL, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis[J]. J Oral Pathol Med, 2018,47(7):633-640.
doi: 10.1111/jop.12726 pmid: 29738071
[3] Lodi G, Porter S. Management of potentially mali-gnant disorders: evidence and critique[J]. J Oral Pathol Med, 2007,37(2):63-69.
doi: 10.1111/j.1600-0714.2007.00575.x pmid: 18197849
[4] van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable[J]. Med Oral Patol Oral Cir Bucal, 2014,19(4):e386-e390.
doi: 10.4317/medoral.20205 pmid: 24905952
[5] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424.
doi: 10.3322/caac.v68.6
[6] Sasahira T, Kirita T. Hallmarks of cancer-related newly prognostic factors of oral squamous cell carcinoma[J]. Int J Mol Sci, 2018,19(8):E2413.
pmid: 30115834
[7] Chi AC, Day TA, Neville BW. Oral cavity and oro-pharyngeal squamous cell carcinoma: an update[J]. CA Cancer J Clin, 2015,65(5):401-421.
pmid: 26215712
[8] Mroueh R, Haapaniemi A, Saarto T, et al. Non-cura-tive treatment of patients with oral tongue squamous-cell carcinoma[J]. Eur Arch Otorhinolaryngol, 2019,276(7):2039-2045.
doi: 10.1007/s00405-019-05456-y pmid: 31069467
[9] Sroussi HY, Epstein JB, Bensadoun RJ, et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis[J]. Cancer Med, 2017,6(12):2918-2931.
doi: 10.1002/cam4.1221 pmid: 29071801
[10] van Straten D, Mashayekhi V, de Bruijn HS, et al. Oncologic photodynamic therapy: basic principles, current clinical status and future directions[J]. Cancers (Basel), 2017,9(2):E19.
[11] Saini R, Lee NV, Liu KY, et al. Prospects in the ap-plication of photodynamic therapy in oral cancer and premalignant lesions[J]. Cancers (Basel), 2016,8(9):E83.
[12] Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update[J]. CA Cancer J Clin, 2011,61(4):250-281.
doi: 10.3322/caac.20114 pmid: 21617154
[13] Tan IB, Dolivet G, Ceruse P, et al. Temoporfin-me-diated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study[J]. Head Neck, 2010,32(12):1597-1604.
pmid: 20848401
[14] Figueira JA, Veltrini VC. Photodynamic therapy in oral potentially malignant disorders—critical litera-ture review of existing protocols[J]. Photodiagnosis Photodyn Ther, 2017,20:125-129.
doi: 10.1016/j.pdpdt.2017.09.007 pmid: 28918177
[15] Rak J, Pouckova P, Benes J, et al. Drug delivery sys-tems for phthalocyanines for photodynamic therapy[J]. Anticancer Res, 2019,39(7):3323-3339.
doi: 10.21873/anticanres.13475 pmid: 31262853
[16] Chen QM, Dan HX, Tang F, et al. Photodynamic the-rapy guidelines for the management of oral leuco-plakia[J]. Int J Oral Sci, 2019,11(2):14.
doi: 10.1038/s41368-019-0047-0 pmid: 30971683
[17] Zhao J, Duan L, Wang AH, et al. Insight into the efficiency of oxygen introduced photodynamic therapy (PDT) and deep PDT against cancers with various assembled nanocarriers[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2020,12(1):e1583.
doi: 10.1002/wnan.1583 pmid: 31566931
[18] Lin HP, Chen HM, Yu CH, et al. Topical photody-namic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia[J]. J Oral Pathol Med, 2010,39(8):624-630.
pmid: 21054548
[19] Yu CH, Lin HP, Chen HM, et al. Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light-emitting diode or laser light[J]. Lasers Surg Med, 2009,41(9):628-633.
doi: 10.1002/lsm.20841 pmid: 19816916
[20] Jin X, Xu H, Deng J, et al. Photodynamic therapy for oral potentially malignant disorders[J]. Photodia-gnosis Photodyn Ther, 2019,28:146-152.
[21] Henderson BW, Busch TM, Snyder JW. Fluence rate as a modulator of PDT mechanisms[J]. Lasers Surg Med, 2006,38(5):489-493.
pmid: 16615136
[22] Chen HM, Yu CH, Tu PC, et al. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photo-dynamic therapy[J]. Lasers Surg Med, 2005,37(2):114-122.
pmid: 16037967
[23] Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies[J]. J Oral Pathol Med, 2016,45(3):155-166.
[24] Lyu MY, Guo YS, Li S, et al. Hospital-based epi-demiological and clinical characterisation of the malignant transformation of oral leukoplakia in a Chinese population[J]. Int Dent J, 2017,67(4):252-259.
pmid: 28276054
[25] Maloth KN, Velpula N, Kodangal S, et al. Photody-namic therapy—a non-invasive treatment modality for precancerous lesions[J]. J Lasers Med Sci, 2016,7(1):30-36.
pmid: 27330695
[26] Han Y, Xu S, Jin JQ, et al. Primary clinical evaluation of photodynamic therapy with oral leukoplakia in Chinese patients[J]. Front Physiol, 2018,9:1911.
pmid: 30723421
[27] Selvam NP, Sadaksharam J, Singaravelu G, et al. Treatment of oral leukoplakia with photodynamic therapy: a pilot study[J]. J Cancer Res Ther, 2015,11(2):464-467.
pmid: 26148619
[28] Shafirstein G, Friedman A, Siegel E, et al. Using 5-aminolevulinic acid and pulsed dye laser for pho-todynamic treatment of oral leukoplakia[J]. Arch Otolaryngol Head Neck Surg, 2011,137(11):1117-1123.
doi: 10.1001/archoto.2011.178 pmid: 22106236
[29] Chen HM, Yu CH, Tsai T, et al. Topical 5-aminolevu-linic acid-mediated photodynamic therapy for oral verrucous hyperplasia, oral leukoplakia and oral erythroleukoplakia[J]. Photodiagnosis Photodyn Ther, 2007,4(1):44-52.
pmid: 25047191
[30] Li YT, Wang BJ, Zheng SW, et al. Photodynamic therapy in the treatment of oral leukoplakia: a syste-matic review[J]. Photodiagnosis Photodyn Ther, 2019,25:17-22.
pmid: 30391342
[31] Pietruska M, Sobaniec S, Bernaczyk P, et al. Clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia[J]. Photodiagnosis Photodyn Ther, 2014,11(1):34-40.
pmid: 24211597
[32] Chen HM, Cheng SJ, Chiang. Topical photodynamic therapy is the first-line treatment of choice for oral erythroleukoplakia and oral verrucous hyperplasia[J]. J Formos Med Assoc, 2015,114(7):567-568.
pmid: 25937480
[33] Wong SJ, Campbell B, Massey B, et al. A phase Ⅰ trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia[J]. Oral Oncol, 2013,49(9):970-976.
pmid: 23845699
[34] Prasanna SW, Ingle E, Aruna PR, et al. Photody-namic therapy of oral leukoplakia and oral lichen planus using methylene blue: a pilot study[J]. J Innov Opt Health Sci, 2015,8(1):1540005.
[35] Sulewska M, Duraj E, Sobaniec S, et al. A clinical evaluation of the efficacy of photodynamic therapy in the treatment of erosive oral lichen planus: a case series[J]. Photodiagnosis Photodyn Ther, 2017,18:12-19.
pmid: 28119140
[36] Bakhtiari S, Azari-Marhabi S, Mojahedi SM, et al. Comparing clinical effects of photodynamic therapy as a novel method with topical corticosteroid for treatment of oral lichen planus[J]. Photodiagnosis Photodyn Ther, 2017,20:159-164.
pmid: 28669793
[37] Mostafa D, Moussa E, Alnouaem M. Evaluation of photodynamic therapy in treatment of oral erosive lichen planus in comparison with topically applied corticosteroids[J]. Photodiagnosis Photodyn Ther, 2017,19:56-66.
doi: 10.1016/j.pdpdt.2017.04.014 pmid: 28450262
[38] Sulewska M, Duraj E, Sobaniec S, et al. A clinical evaluation of efficacy of photodynamic therapy in treatment of reticular oral lichen planus: a case series[J]. Photodiagnosis Photodyn Ther, 2019,25:50-57.
doi: 10.1016/j.pdpdt.2018.11.009 pmid: 30447415
[39] Rakesh N, Clint JB, Reddy SS, et al. Clinical eva-luation of photodynamic therapy for the treatment of refractory oral lichen planus—a case series[J]. Photodiagnosis Photodyn Ther, 2018,24:280-285.
doi: 10.1016/j.pdpdt.2018.09.011 pmid: 30261326
[40] Mirza S, Rehman N, Alrahlah A, et al. Efficacy of photodynamic therapy or low level laser therapy against steroid therapy in the treatment of erosive-atrophic oral lichen planus[J]. Photodiagnosis Photo-dyn Ther, 2018,21:404-408.
[41] Sobaniec S, Bernaczyk P, Pietruski J, et al. Clinical assessment of the efficacy of photodynamic therapy in the treatment of oral lichen planus[J]. Lasers Med Sci, 2013,28(1):311-316.
doi: 10.1007/s10103-012-1153-9 pmid: 22814895
[42] Schweitzer VG, Somers ML. PHOTOFRIN-media-ted photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx[J]. Lasers Surg Med, 2010,42(1):1-8.
doi: 10.1002/lsm.20881 pmid: 20077493
[43] Toratani S, Tani R, Kanda, et al. Photodynamic therapy using photofrin and excimer dye laser treatment for superficial oral squamous cell carcinomas with long-term follow up[J]. Photodiagnosis Photodyn Ther, 2016,14:104-110.
pmid: 26747657
[44] Karakullukcu B, van Oudenaarde K, Copper MP, et al. Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients[J]. Eur Arch Otorhinolaryngol, 2011,268(2):281-288.
doi: 10.1007/s00405-010-1361-5 pmid: 20706842
[45] Jerjes W, Upile T, Hamdoon Z, et al. Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinoma[J]. Lasers Surg Med, 2011,43(6):463-469.
doi: 10.1002/lsm.21071 pmid: 21761416
[46] Durbec M, Cosmidis A, Fuchsmann C, et al. Efficacy and safety of photodynamic therapy with temoporfin in curative treatment of recurrent carcinoma of the oral cavity and oropharynx[J]. Eur Arch Otorhino-laryngol, 2013,270(4):1433-1439.
[47] Ikeda H, Tobita T, Ohba S, et al. Treatment outcome of photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia[J]. Photodiagnosis Photodyn Ther, 2013,10(3):229-235.
pmid: 23993848
[48] Ikeda H, Ohba S, Egashira K, et al. The effect of photodynamic therapy with talaporfin sodium, a second-generation photosensitizer, on oral squamous cell carcinoma: a series of eight cases[J]. Photodia-gnosis Photodyn Ther, 2018,21:176-180.
[49] Yoshida T, Tokashiki R, Ito H, et al. Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration[J]. Auris Nasus Larynx, 2008,35(4):545-551.
pmid: 18242905
[50] Cerrati EW, Nguyen SA, Farrar JD, et al. The ef-ficacy of photodynamic therapy in the treatment of oral squamous cell carcinoma: a meta-analysis[J]. Ear Nose Throat J, 2015,94(2):72-79.
doi: 10.1177/014556131509400208 pmid: 25651350
[51] Elbers JBW, Al-Mamgani A, Paping D, et al. De-finitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity[J]. Oral Oncol, 2017,75:163-168.
pmid: 29224815
[52] Jerjes W, Upile T, Radhi H, et al. Photodynamic therapy and end-stage tongue base cancer: short communication[J]. Head Neck Oncol, 2011,3:49.
pmid: 22152039
[53] Zhang YF, Zhang LL, Yang DG, et al. Treatment of oral refractory large area mucosal leukoplakia with CO2 laser combined with photodynamic therapy: case report[J]. Photodiagnosis Photodyn Ther, 2017,20:193-195.
doi: 10.1016/j.pdpdt.2017.10.006 pmid: 29037909
[54] Wang YY, Yang YD, Yang YC, et al. Surgery com-bined with topical photodynamic therapy for the treatment of squamous cell carcinoma of the lip[J]. Photodiagnosis Photodyn Ther, 2016,14:170-172.
doi: 10.1016/j.pdpdt.2016.04.008 pmid: 27102062
[55] Vander Poorten V, Meulemans J, Nuyts S, et al. Pos-toperative photodynamic therapy as a new adjuvant treatment after robot-assisted salvage surgery of recurrent squamous cell carcinoma of the base of tongue[J]. World J Surg Oncol, 2015,13:214.
doi: 10.1186/s12957-015-0630-6 pmid: 26179387
[56] Shi SR, Zhang LY, Zhu MQ, et al. Reactive oxygen species-responsive nanoparticles based on PEGlated prodrug for targeted treatment of oral tongue squa-mous cell carcinoma by combining photodynamic therapy and chemotherapy[J]. ACS Appl Mater Inter-faces, 2018,10(35):29260-29272.
[1] 周金阔,张晋弘,史晓晶,刘广顺,姜磊,刘倩峰. 长链非编码RNA小核仁RNA宿主基因22调控微小RNA-27b-3p对口腔鳞状细胞癌细胞增殖、侵袭和迁移的影响[J]. 国际口腔医学杂志, 2024, 51(1): 52-59.
[2] 李立恒,王蕊,王晓明,张智轶,张璇,安峰,王芹,张凡. 环状RNA hsa_circ_0085576调控微小RNA-498/B细胞特异性莫洛尼鼠白血病病毒整合位点1轴对口腔鳞状细胞癌细胞迁移和侵袭的影响[J]. 国际口腔医学杂志, 2024, 51(1): 60-67.
[3] 吴佳敏,夏斌,杨禾丰,许彪. 癌相关成纤维细胞在口腔鳞状细胞癌微环境中作用的研究进展[J]. 国际口腔医学杂志, 2023, 50(6): 711-717.
[4] 柳江龙, 买买提吐逊·吐尔地. 超声造影在口腔鳞状细胞癌颈部转移性淋巴结诊断中的研究进展[J]. 国际口腔医学杂志, 2023, 50(5): 514-520.
[5] 盛南宁,王珏,南欣荣. 性别决定基因盒9在口腔鳞状细胞癌作用机制和治疗中的研究进展[J]. 国际口腔医学杂志, 2023, 50(3): 314-320.
[6] 李潭,梁新华. 盘状蛋白结构域受体1在调控恶性肿瘤进展和治疗中的作用[J]. 国际口腔医学杂志, 2023, 50(2): 230-236.
[7] 赵卓平,辛鹏飞,高阳,张彩凤,张宽收,刘青梅. 光热治疗在口腔鳞状细胞癌治疗中的研究进展[J]. 国际口腔医学杂志, 2022, 49(4): 462-470.
[8] 马玉,左玉,张鑫. 光动力疗法辅助治疗牙周炎治疗效果的Meta分析[J]. 国际口腔医学杂志, 2022, 49(3): 305-316.
[9] 江涵,神应强,陈谦明. 毒蕈碱受体通过Yes相关蛋白信号对口腔鳞状细胞癌生物学行为的实验研究[J]. 国际口腔医学杂志, 2022, 49(2): 138-143.
[10] 蒋宇磊,夏斌,饶南荃,杨禾丰,许彪. 外泌体在口腔鳞状细胞癌恶性进展及诊疗应用的研究[J]. 国际口腔医学杂志, 2021, 48(6): 711-717.
[11] 甘建国,高攀,王晓毅. 循环肿瘤细胞与口腔鳞状细胞癌相关性的研究进展[J]. 国际口腔医学杂志, 2021, 48(2): 205-212.
[12] 黄俊文,乔洁,梅子,陈茁,李杨,乔彬. 脂多糖结合蛋白在口腔鳞状细胞癌中的表达及其临床意义[J]. 国际口腔医学杂志, 2021, 48(1): 50-57.
[13] 郝福,宁毅,孙睿,郑晓旭. 口腔鳞状细胞癌中转化因子2β的表达及潜在的临床意义[J]. 国际口腔医学杂志, 2020, 47(2): 159-165.
[14] 薛伶俐,李雅冬. 经首次根治性手术治疗口腔鳞状细胞癌患者的生存相关影响因素分析[J]. 国际口腔医学杂志, 2020, 47(2): 166-174.
[15] 董云梅,陶艳,周瑜. 口腔黏膜癌变过程中血清生化标志物的研究进展[J]. 国际口腔医学杂志, 2020, 47(1): 43-50.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 王昆润. 二甲亚砜和双氯芬酸并用治疗根尖周炎[J]. 国际口腔医学杂志, 1999, 26(06): .
[2] 汤庆奋,王学侠. 17β-雌二醇对人类阴道和口腔颊粘膜的渗透性[J]. 国际口腔医学杂志, 1999, 26(06): .
[3] 潘劲松. 颈总动脉指压和颈内动脉球囊阻断试验在大脑血液动力学中的不同影响[J]. 国际口腔医学杂志, 1999, 26(05): .
[4] 王昆润. 后牙冠根斜形牙折的治疗[J]. 国际口腔医学杂志, 1999, 26(05): .
[5] 杨锦波. 嵌合体防龋疫苗的研究进展[J]. 国际口腔医学杂志, 1999, 26(05): .
[6] 王昆润. 下颔骨成形术用网状钛板固定植骨块[J]. 国际口腔医学杂志, 1999, 26(04): .
[7] 汪月月,郭莉莉. 口腔机能与老化—痴呆危险因素流行病学研究[J]. 国际口腔医学杂志, 1999, 26(04): .
[8] 丁刚. 应用硬组织代用品种植体行丰颏术[J]. 国际口腔医学杂志, 1999, 26(04): .
[9] 田磊. 局部应用脂多糖后结合上皮反应性增生的变化[J]. 国际口腔医学杂志, 1999, 26(04): .
[10] 戴青. 口腔念珠菌病的新分类[J]. 国际口腔医学杂志, 1999, 26(04): .